Differential role for interleukin-6 during Francisella tularensis infection with virulent and vaccine strains.
作者信息
Laws Thomas R, Clark Graeme, D'Elia Riccardo V
出版信息
Infect Immun. 2013 Aug;81(8):3055-6. doi: 10.1128/IAI.00234-13. Epub 2013 May 28.
Abstract
摘要
相似文献
1
Differential role for interleukin-6 during Francisella tularensis infection with virulent and vaccine strains.白细胞介素-6在强毒株和疫苗株土拉弗朗西斯菌感染过程中的不同作用。
Infect Immun. 2013 Aug;81(8):3055-6. doi: 10.1128/IAI.00234-13. Epub 2013 May 28.
2
Interleukin-17 protects against the Francisella tularensis live vaccine strain but not against a virulent F. tularensis type A strain.白细胞介素-17 可预防 弗氏柠檬酸杆菌活疫苗株，但不能预防毒力强的弗氏柠檬酸杆菌 A 型菌株。
Infect Immun. 2013 Sep;81(9):3099-105. doi: 10.1128/IAI.00203-13. Epub 2013 Jun 17.
3
Evaluation of Francisella tularensis ΔpdpC as a candidate live attenuated vaccine against respiratory challenge by a virulent SCHU P9 strain of Francisella tularensis in a C57BL/6J mouse model.在C57BL/6J小鼠模型中，评估土拉弗朗西斯菌ΔpdpC作为候选减毒活疫苗，抵抗土拉弗朗西斯菌强毒株SCHU P9引起的呼吸道感染的效果。
Microbiol Immunol. 2018 Jan;62(1):24-33. doi: 10.1111/1348-0421.12555. Epub 2018 Jan 1.
4
Mice sublethally infected with Francisella novicida U112 develop only marginal protective immunity against systemic or aerosol challenge with virulent type A or B strains of F. tularensis.用新凶手弗朗西斯菌U112进行亚致死感染的小鼠，对强毒A型或B型土拉弗朗西斯菌的全身或气溶胶攻击仅产生微弱的保护性免疫。
Microb Pathog. 2004 Aug;37(2):107-10. doi: 10.1016/j.micpath.2004.04.005.
5
Adaptive Immunity to and Considerations for Vaccine Development.适应性免疫与疫苗开发的考虑因素。
Front Cell Infect Microbiol. 2018 Apr 6;8:115. doi: 10.3389/fcimb.2018.00115. eCollection 2018.
6
Susceptibility of various mouse strains to systemically- or aerosol-initiated tularemia by virulent type A Francisella tularensis before and after immunization with the attenuated live vaccine strain of the pathogen.在用该病原体的减毒活疫苗株免疫前后，各种小鼠品系对强毒A型土拉弗朗西斯菌全身感染或气溶胶引发的兔热病的易感性。
Vaccine. 2004 Jun 2;22(17-18):2116-21. doi: 10.1016/j.vaccine.2003.12.003.
7
Identification of Francisella tularensis outer membrane protein A (FopA) as a protective antigen for tularemia.鉴定土拉弗朗西斯菌外膜蛋白 A（FopA）作为土拉菌病的保护性抗原。
Vaccine. 2011 Sep 16;29(40):6941-7. doi: 10.1016/j.vaccine.2011.07.075. Epub 2011 Jul 29.
8
Successful protection against tularemia in C57BL/6 mice is correlated with expansion of Francisella tularensis-specific effector T cells.在C57BL/6小鼠中成功预防土拉菌病与土拉热弗朗西斯菌特异性效应T细胞的扩增相关。
Clin Vaccine Immunol. 2015 Jan;22(1):119-28. doi: 10.1128/CVI.00648-14. Epub 2014 Nov 19.
9
Virulence determinants and protective antigens of Francisella tularensis.土拉弗朗西斯菌的毒力决定因素和保护性抗原。
Curr Opin Microbiol. 2003 Feb;6(1):66-71. doi: 10.1016/s1369-5274(03)00002-x.
10
Tularemia vaccines.兔热病疫苗
Folia Microbiol (Praha). 2016 Nov;61(6):495-504. doi: 10.1007/s12223-016-0461-z. Epub 2016 May 19.
引用本文的文献
1
The immune response to .对……的免疫反应。 （你提供的原文不完整，以上是根据现有内容翻译的）
Front Microbiol. 2025 Apr 25;16:1549343. doi: 10.3389/fmicb.2025.1549343. eCollection 2025.
2
Protective potential of outer membrane vesicles derived from a virulent strain of .源自. 强毒株的外膜囊泡的保护潜力
Front Microbiol. 2024 Mar 12;15:1355872. doi: 10.3389/fmicb.2024.1355872. eCollection 2024.
3
Common Host Responses in Murine Aerosol Models of Infection Caused by Highly Virulent Gram-Negative Bacteria from the Genera Burkholderia, Francisella and Yersinia.由伯克霍尔德菌属、弗朗西斯菌属和耶尔森菌属高毒力革兰氏阴性细菌引起的小鼠气溶胶感染模型中的常见宿主反应
Pathogens. 2019 Sep 21;8(4):159. doi: 10.3390/pathogens8040159.
4
Intradermal Delivery of Bacteria by Using Microneedle Arrays.微针阵列介导的细菌皮内递药。
Infect Immun. 2018 Aug 22;86(9). doi: 10.1128/IAI.00406-18. Print 2018 Sep.
5
Uncovering the components of the Francisella tularensis virulence stealth strategy.揭示土拉弗朗西斯菌毒力隐身策略的组成部分。
Front Cell Infect Microbiol. 2014 Mar 7;4:32. doi: 10.3389/fcimb.2014.00032. eCollection 2014.
6
Immunotherapy for tularemia.土拉菌病的免疫疗法。
Virulence. 2013 Nov 15;4(8):859-70. doi: 10.4161/viru.25454. Epub 2013 Jun 19.
本文引用的文献
1
Targeting the "cytokine storm" for therapeutic benefit.针对“细胞因子风暴”以获得治疗益处。
Clin Vaccine Immunol. 2013 Mar;20(3):319-27. doi: 10.1128/CVI.00636-12. Epub 2013 Jan 2.
2
Interleukin-6 is essential for primary resistance to Francisella tularensis live vaccine strain infection.白细胞介素-6 对于对抗兔热病活菌疫苗株感染的原发性抵抗至关重要。
Infect Immun. 2013 Feb;81(2):585-97. doi: 10.1128/IAI.01249-12. Epub 2012 Dec 10.
3
Infection of mice with Francisella as an immunological model.用弗朗西斯菌感染小鼠作为一种免疫学模型。
Curr Protoc Immunol. 2011 Apr;Chapter 19:Unit 19.14. doi: 10.1002/0471142735.im1914s93.
4
Editorial: Proinflammatory cytokines in pneumonic tularemia: too much too late?社论：肺炎型兔热病中的促炎细胞因子：是否过多且过晚？
J Leukoc Biol. 2009 Sep;86(3):469-70. doi: 10.1189/jlb.0309119.
5
Intranasal interleukin-12 treatment for protection against respiratory infection with the Francisella tularensis live vaccine strain.经鼻内给予白细胞介素-12以预防用土拉弗朗西斯菌活疫苗株引起的呼吸道感染。
Infect Immun. 2005 Apr;73(4):2306-11. doi: 10.1128/IAI.73.4.2306-2311.2005.
Zotero 插件